Related Experiment Video

Updated: Jun 26, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
08:55

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

New therapeutic agents in ovarian cancer

Fiona Collinson1, Gordon Jayson

  • 1University of Leeds, St James' University Hospital, Leeds, UK. fjcollinson@doctors.org.uk

Current Opinion in Obstetrics & Gynecology
|January 7, 2009
PubMed
Abstract

Insights

New targeted therapies show promise for epithelial ovarian cancer, the deadliest gynecological cancer. Further research is needed to integrate these treatments and identify biomarkers for personalized medicine.

Area of Science:

  • Gynecological Oncology
  • Medical Research
  • Pharmacology

Background:

  • Epithelial ovarian cancer is the leading cause of gynecological cancer mortality.
  • Current management strategies require improvement for better patient outcomes.
  • Early detection and novel therapeutic options are critical unmet needs.

Purpose of the Study:

  • To review promising targeted therapies for epithelial ovarian cancer.
  • To discuss the evidence supporting the use of these novel agents.
  • To highlight the need for further research in treatment integration and patient selection.

Main Methods:

  • Literature review of recent advancements in ovarian cancer therapeutics.
  • Analysis of clinical evidence for targeted therapy agents.
  • Discussion of future research directions in personalized medicine.

Main Results:

  • Several targeted therapies, including vascular endothelial growth factor inhibitors, poly-ADP-ribose polymerase inhibitors, and folate receptor inhibitors, demonstrate potential.
  • These novel agents offer promising avenues for improving epithelial ovarian cancer treatment.
  • Evidence supporting their use is under active investigation.

Conclusions:

  • Further research is essential to determine optimal integration of novel therapies.
  • Biomarkers are needed to predict treatment toxicity and patient response.
  • Individualized therapy for epithelial ovarian cancer requires significant further development.

More Related Videos

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-107:59

Evaluating the Angiogenetic Properties of Ovarian Cancer Stem-Like Cells using the Three-Dimensional Co-Culture System, NICO-1

Published on: December 5, 2020

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...